| Screening |
qSOFA suggested as bedside screen outside ICU. Score ≥ 2 triggers SOFA assessment. |
NEWS/NEWS2/MEWS/SIRS now recommended OVER qSOFA. qSOFA has poor sensitivity -misses too many septic patients. Should not be sole screening tool. Sepsis remains a clinical diagnosis. |
Major |
| Fluid Type |
Crystalloids recommended. No clear preference between balanced crystalloids and normal saline. |
Balanced crystalloids (LR/PlasmaLyte) now suggested over 0.9% saline. Exception: TBI patients -use NS (risk of cerebral edema with hypotonic solutions). |
Major |
| Fluid Volume |
30 mL/kg crystalloid within 3 hours for sepsis-induced hypoperfusion. Conditional recommendation. |
30 mL/kg still suggested (conditional, unchanged strength). Greater focus on individualization and dynamic reassessment after each bolus. New: after initial 30 mL/kg with persistent hypoperfusion, suggest either liberal or restrictive strategy based on individual factors. Supported by CLOVERS, 2023: no difference between restrictive (~1.8L) and liberal (~3.8L). |
Moderate |
| Fluid Removal |
Not addressed. |
New: fluid removal (de-resuscitation) after stabilization now addressed. Fluid overload harms -actively manage it once resuscitation is complete. |
New |
| Vasopressor Access |
Start vasopressors via central venous catheter. |
Peripheral vasopressor start now acceptable. Don't delay pressors waiting for central line placement. Start NE peripherally, establish central access in parallel. |
Major |
| Vasopressor Choice |
Norepinephrine first-line (strong recommendation). Vasopressin or epinephrine as second-line. Against dopamine as alternative. |
NE still first-line but downgraded to conditional ("suggest") from strong recommendation. NE → vasopressin → epinephrine order unchanged. Dopamine remains discouraged. Against angiotensin II, terlipressin, or selepressin. |
Moderate |
| MAP Target |
MAP ≥ 65 mmHg. Higher targets (80+) showed no benefit. |
MAP ≥ 65 mmHg unchanged for general population. New: for adults โฅ 65 years, suggest initial MAP 60-65 mmHg over higher targets. Spares vasopressor exposure without increasing mortality. |
Major |
| Corticosteroids |
Suggested if ongoing vasopressor requirement. (This was the 2021 reversal of the 2016 recommendation against routine steroids.) |
Maintained from 2021. Hydrocortisone 200 mg/day (50 mg q6h) for septic shock with ongoing vasopressor requirement. Shortens shock duration. ADRENAL 2018 + APROCCHSS 2018 enrolled patients on pressors โฅ 4h, but no specific wait time is mandated. |
Maintained |
| Antibiotic Timing |
Broad-spectrum antibiotics within 1 hour of sepsis recognition for ALL patients. |
Now tiered: 1 hour for septic shock, 3 hours for sepsis without shock. Recognizes that not all sepsis requires the same urgency. Blood cultures before antibiotics when possible. |
Major |
| Antibiotic Optimization |
Focus on early administration. De-escalation at 48-72h. |
New section on antibiotic optimization beyond timing. Stewardship emphasized. De-escalation reinforced. Prehospital antibiotics may reduce mortality (OR 0.58, very low certainty). |
New |
| Anti-Anaerobic Coverage |
Not specifically addressed. |
New: Avoid anti-anaerobic antibiotics (e.g., metronidazole, pip-tazo anaerobic component) in patients at LOW risk for anaerobic infection. Risk factors for anaerobic infection: intra-abdominal source, deep gynecologic/obstetric infection, necrotizing soft tissue, head & neck, CNS abscess. Most lung and UTI sources are aerobic, don't reflexively add anaerobic coverage. |
New |
| Beta-Lactam Infusion |
Not specifically addressed. |
New: recommend (strong) prolonged infusion of beta-lactams for maintenance dosing (after initial loading dose) over bolus administration. Moderate certainty evidence. Sustained drug levels improve time-dependent killing and reduce mortality. |
New |
| Fluid Responsiveness |
Not specifically addressed. |
New: suggest using dynamic measures (passive leg raise, stroke volume variation, pulse pressure variation) over physical exam or static measures alone to guide initial fluid resuscitation. |
New |
| Blood Purification |
Suggested against PMMA hemoperfusion. Insufficient evidence for other modalities. |
Suggest against blood purification therapies including hemoperfusion, high-dose hemofiltration, and plasma exchange for sepsis/septic shock. |
Moderate |
| Lactate |
Measure lactate. Remeasure if initial > 2 mmol/L. Guide resuscitation to normalize lactate. |
Reframed. Serial lactate still recommended, but do NOT use elevated lactate as reflexive indication for more fluids. Lactate elevation is multifactorial, only a small percentage is from hypovolemic hypoperfusion. Individualize fluid therapy after initial bolus based on dynamic measures, not lactate normalization alone. |
Moderate |
| Albumin |
Suggested as supplement to crystalloids for patients receiving large volumes. |
Reversed: now suggests crystalloids alone over crystalloids + albumin for initial resuscitation. Exception: albumin may be appropriate after large crystalloid volumes or in cirrhosis. Avoid in TBI. |
Major |
| Code Sepsis |
Not addressed. |
New: "Code sepsis" huddle protocols suggested. Structured multidisciplinary response to sepsis recognition, similar to code blue or stroke codes. |
New |
| Institutional QI |
Performance improvement mentioned. |
Institutional performance improvement programs now formally recommended. Sepsis education, bundle compliance monitoring, outcome tracking. |
Moderate |
| Post-Discharge |
Not addressed. |
New: post-sepsis discharge care now addressed. Psychological rehabilitation (PTSD, depression, anxiety). Physical rehabilitation. Long-term follow-up. Sepsis survivors face increased mortality for years after discharge. |
New |
| Pediatric |
Separate pediatric guidelines with 77 recommendations. |
Updated: 68-expert panel, 20 new topics. POCUS conditionally recommended for resuscitation guidance. 30-40% of children surviving ICU-level sepsis face lasting health issues -long-term follow-up now addressed. |
Major |